Earnings after the market close
$Tilray Brands(TLRY.US$ reported a 4th Quarter December 2019 loss of $0.62 per share on revenue of $46.9 million. The consensus estimate was a loss of $0.34 per share on revenue of $55.4 million.
$FibroGen(FGEN.US$ reported a 4th Quarter December 2019 loss of $1.12 per share on revenue of $8.0 million. The consensus estimate was a loss of $0.62 per share on revenue of $30.7 million. FibroGen Inc is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.
$Appfolio(APPF.US$reported 4th Quarter December 2019 earnings of $0.12 per share on revenue of $67.4 million. The consensus earnings estimate was $0.03 per share on revenue of $66.6 million. The company said it expects 2020 revenue of $312.0 million to $320.0 million. The current consensus estimate is revenue of $323.8 million for the year ending December 31, 2020.
$FibroGen(FGEN.US$ reported a 4th Quarter December 2019 loss of $1.12 per share on revenue of $8.0 million. The consensus estimate was a loss of $0.62 per share on revenue of $30.7 million. FibroGen Inc is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.
$Appfolio(APPF.US$reported 4th Quarter December 2019 earnings of $0.12 per share on revenue of $67.4 million. The consensus earnings estimate was $0.03 per share on revenue of $66.6 million. The company said it expects 2020 revenue of $312.0 million to $320.0 million. The current consensus estimate is revenue of $323.8 million for the year ending December 31, 2020.
免责声明:此内容由Moomoo Technologies Inc.提供,仅用于信息交流和教育目的。
更多信息
评论
登录发表评论